866-997-4948(US-Canada Toll Free)

Global Markets for Enzyme Inhibitors

Published By :

BCC Research

Published Date : Dec 2017

Category :

Biotechnology

No. of Pages : N/A

The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.

Report Includes

  • 55 data tables and 52 additional tables.
  • An overview of the global markets for enzyme inhibitors.
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Detailed analysis of the enzyme inhibitors industry structure. 
  • A look at applications for enzyme inhibitors, with emphasis on the usage of the inhibitors in therapeutic categories and various disease sectors.
  • Coverage of significant patents and their allotments in each category.
  • Profiles of major players in the industry, including:Abbott Laboratories, AbbVie Inc., Amgen, Inc., AstraZeneca PLC, Bayer Ag, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb, Cipla USA Inc.

Report Scope

Enzyme inhibitors drugs are drugs that help to treat chronic diseases such as cardiovascular disease, gastrointestinal disease, acquired immunodeficiency syndrome, cancer, hepatitis, men’s-health-related conditions (erectile dysfunction, benign prostatic hyperplasia, alopecia), diabetes and various others (rheumatoid arthritis, psoriasis, Parkinson’s disease, influenza, etc.). This report focuses on the global market of enzyme inhibitor drug products and provides an updated review including its applications in various arenas of disease sectors. The scope of the study is global. BCC Research analyzes each market and its application, new products and advancements, market projections and market shares. This study surveys each market in all the geographic regions including North America, Europe and emerging markets. The emerging market category covers all countries such as India, China, South Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America and so forth.

Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the enzyme inhibitor drugs industry. Some of the major players of the market include, F. Hoffmann-La Roche, Novartis AG, Pfizer Inc., AstraZeneca plc, Merck & Co., Gilead Sciences, Janssen Pharmaceuticals, ViiV Healthcare, Eli Lilly and Co., Takeda Pharmaceuticals, Bayer AG, Amgen Inc., AbbVie , Eisai Inc., Teva Pharmaceuticals Inc. and others.

BCC Research analyzes the current market situation by discussing the market drivers, restraints, challenges and opportunities. The market projections and market shares are examined for each region and type. The latest news pieces including new products, mergers and acquisitions in each market are also dealt with in sufficient detail. Also included in the report are relevant patent analysis and comprehensive profiles of companies that are dominant in the enzyme inhibitors industry.

The period of the current report saw an enormous number of new approvals and new indication approvals. New enzyme inhibitor categories gained entries in the market. In comparison with the last report, therefore, a number of new enzyme inhibitor types have been included in this report. They are integrase inhibitors, PCSK9 inhibitors, PARP inhibitors, PDE4 inhibitors, DPP-4 inhibitors and SGLT-2 inhibitors. Certain other categories that had mentionable markets were also included such as AChEIs, 5-ARI inhibitors, XOIs and MAOIs. The market had started to decline due to patent expiries since 2010–2011, and the trend was seen to accelerate during the period of the current report.

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Definitions
Enzymes
Coenzymes
Cofactor
Active Site
Substrate
Enzyme Inhibitors
Enzymes
Enzyme Specificity
Factors Affecting Enzymatic Action
Classification of Enzymes
Enzymes in the Human Body
Enzyme Inhibitors
Uses of Enzyme Inhibitors
Mechanism of Enzyme Inhibitors
Types of Enzyme Inhibitors
Classification of Enzyme Inhibitors
Market Segments
Proton Pump Inhibitors
Protease Inhibitors
Reverse Transcriptase Inhibitors
Kinase Inhibitors
Statins
Aromatase Inhibitors
Phosphodiesterase Type 4 Inhibitors
Phosphodiesterase Type 5 Inhibitors
Neuraminidase Inhibitors
Angiotensin-Converting Enzyme Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Xanthine oxidase inhibitors
COX-2 Inhibitors
5-Alpha Reductase Inhibitors
Dipeptidyl Peptidase-4 Inhibitors or Gliptins
Sodium-Glucose Co-Transporter-2 Inhibitors or Gliflozins
Integrase Inhibitors
Monoamine oxidase inhibitors (MOAIs)
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Acetylcholinesterase inhibitors
Aldose Reductase Inhibitors
Chapter 4 Market Breakdown by Technology Type and Region
Market by Type
Market Revenue
Market Share of Enzyme Inhibitors by Type
Market by Region
Market Overview
Market Revenue
Market Share
Proton Pump Inhibitors
Protease Inhibitors
Reverse Transcriptase Inhibitors
Kinase Inhibitors
Statins
Aromatase Inhibitors
Phosphodiesterase Type 5 Inhibitors
Neuraminidase Inhibitors
Angiotensin-Converting Enzyme Inhibitors
Poly(ADP-Ribose) Polymerase Inhibitors
Xanthine Oxidase Inhibitors
Phosphodiesterase 4 Inhibitors
Cyclooxygenase Inhibitors
5-Alpha Reductase Inhibitors
Dipeptidyl Peptidase-4 Inhibitors
Sodium-Glucose Co-Transporter-2 Inhibitors
Integrase Inhibitors
Monoamine Oxidase Inhibitors
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Acetylcholinesterase Inhibitors
Chapter 5 Market Breakdown by Application
Global Market Share of Enzyme Inhibitors by Application
Cardiovascular Disease
Gastrointestinal Disorders
Acquired Immunodeficiency Syndrome
Hepatitis
Cancer
Men's Health-Erectile Dysfunction/Benign Prostatic Hyperplasia/Alopecia
Diabetes
Others
Chapter 6 Industry Structure
Proton Pump Inhibitors
Market Leaders
Market Shares
Protease Inhibitors
Market Leaders
Market Shares
Reverse Transcriptase Inhibitors
Market Leaders
Market Shares
Kinase Inhibitors
Market Leaders
Market Shares
Statins
Market Leaders
Market Shares
Aromatase Inhibitors
Market Leaders
Market Shares
Phosphodiesterase Type 5 Inhibitors
Market Leaders
Market Shares
Neuraminidase Inhibitors
Market Leaders
Market Shares
Angiotensin-Converting Enzyme Inhibitors
Market Leaders
Market Shares
Poly(ADP-Ribose) Polymerase Inhibitors
Market Leaders
Market Shares
Xanthine Oxidase Inhibitors
Market Leaders
Market Shares
Phosphodiesterase Type 4 Inhibitors
Market Leaders
Market Shares
Cyclooxygenase Inhibitors
Market Leaders
Market Shares
5-Alpha Reductase Inhibitors
Market Leaders
Market Shares
Dipeptidyl Peptidase-4 Inhibitors
Market Leaders
Market Shares
Sodium-Glucose Co-Transporter-2 Inhibitors
Market Leaders
Market Shares
Integrase Inhibitors
Market Leaders
Market Shares
Monoamine Oxidase Inhibitors
Market Leaders
Market Shares
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Market Leaders
Market Shares
Acetylcholinesterase Inhibitors
Market Leaders
Market Shares
Chapter 7 Patent Review/ New Developments
Patents
Patents by Year
Patents by Type
Patents by Company
Patents by Country
Patents by Assignee
New Product Developments
New Drug Approvals for Enzyme Inhibitors
Pipeline Products for Enzyme Inhibitors
Mergers and Acquisitions
Chapter 8 Analysis of Market Opportunities
Drivers of Enzyme Inhibitors Market
Increasing Aging Population
Increasing Incidence of Diseases
Rise in Healthcare Spending
Direct-to-Consumer Advertising
New/Pipeline Products
New Indications
Mergers and Alliances
Restraints of Enzyme Inhibitors Market
Patent Expirations
Government Regulations
Price Checks
Opportunities for Enzyme Inhibitors Market
Emerging Markets
Favorable Government Policies
Research and Development
Innovation
Prescription to Over-the-Counter Switch
Challenges for Enzyme Inhibitors Market
Changing Regulatory Landscape/Market Fluctuations
Uncertainties in Drug Development
Quality Control
Patent Litigation
Chapter 9 Company Profiles
Chapter 10 Appendix: Abbreviations

List of Table

Summary Table : Global Market for Enzyme Inhibitors, by Type, Through 2022
Table 1 : Development of ACE Inhibitors
Table 2 : Patent Expiries of Important Enzyme Inhibitors from 2013 to 2020
Table 3 : Global Market for Enzyme Inhibitors, by Type, Through 2022
Table 4 : Global Market Share of Enzyme Inhibitors, by Type, 2016
Table 5 : Global Market for Enzyme Inhibitors, by Region, Through 2022
Table 6 : Global Market Share of Enzyme Inhibitors, by Region, 2016
Table 7 : Global Market for Proton Pump Inhibitors, Through 2022
Table 8 : Global Market Share of Proton Pump Inhibitors, by Region, 2016
Table 9 : Global Market for Protease Inhibitors, by Region, Through 2022
Table 10 : Global Market Share of Protease Inhibitors, by Region, 2016
Table 11 : Global Market for Reverse Transcriptase Inhibitors, by Region, Through 2022
Table 12 : Global Market Share of Reverse Transcriptase Inhibitors, by Region, 2016
Table 13 : Global Market for Kinase Inhibitors, by Region, Through 2022
Table 14 : Global Market Share of Kinase Inhibitors, by Region, 2016
Table 15 : Global Market for Statins, by Region, Through 2022
Table 16 : Market Share of Statins, by Region, 2016
Table 17 : Global Market for Aromatase Inhibitors, by Region, Through 2022
Table 18 : Market Share of Aromatase Inhibitors, by Region, 2016
Table 19 : Global Market for Phosphodiesterase 5 Inhibitors, by Region, Through 2022
Table 20 : Market Share of Phosphodiesterase 5 Inhibitors, by Region, 2016
Table 21 : Global Market for Neuraminidase Inhibitors, by Region, Through 2022
Table 22 : Global Market Share of Neuraminidase Inhibitors, by Region, 2016
Table 23 : Global Market for ACE Inhibitors, by Region, Through 2022
Table 24 : Global Market Share of ACE Inhibitors, by Region, 2016
Table 25 : Global Market for PARP Inhibitors, by Region, Through 2022
Table 26 : Global Market Share of PARP Inhibitors, by Region, 2016
Table 27 : Global Market for Xanthine Oxidase Inhibitors, by Region, Through 2022
Table 28 : Global Market Share of Xanthine Oxidase Inhibitors, by Region, 2016
Table 29 : Global Market for Phosphodiesterase 4 Inhibitors, by Region, Through 2022
Table 30 : Global Market Share of Phosphodiesterase 4 Inhibitors, by Region, 2016
Table 31 : Global Market for Cyclooxygenase Inhibitors, by Region, Through 2022
Table 32 : Global Market Share of Cyclooxygenase Inhibitors, by Region, 2016
Table 33 : Global Market for 5-Alpha Reductase Inhibitors, by Region, Through 2022
Table 34 : Market Share of 5-Alpha Reductase Inhibitors, by Region, 2016
Table 35 : Global Market for Dipeptidyl Peptidase-4 Inhibitors, by Region, Through 2022
Table 36 : Global Market Share of Dipeptidyl Peptidase-4 Inhibitors, by Region, 2016
Table 37 : Global Market for SGLT-2 Inhibitors, by Region, Through 2022
Table 38 : Global Market Share of SGLT-2 Inhibitors, by Region, 2016
Table 39 : Global Market for Integrase Inhibitors, by Region, Through 2022
Table 40 : Global Market Share of Integrase Inhibitors, by Region, 2016
Table 41 : Global Market for Monoamine Oxidase Inhibitors, by Region, Through 2022
Table 42 : Market Share of Monoamine Oxidase Inhibitors, by Region, 2016
Table 43 : Global Market for PCSK9 Inhibitors, by Region, Through 2022
Table 44 : Global Market Share of PCSK9 Inhibitors, by Region, 2016
Table 45 : Global Market for Acetylcholinesterase Inhibitors, by Region, Through 2022
Table 46 : Market Share of Acetylcholinesterase Inhibitors, by Region, 2016
Table 47 : Global Market for Enzyme Inhibitors, by Disease Sectors, Through 2022
Table 48 : Global Market Share of Enzyme Inhibitors, by Disease Sectors, 2016
Table 49 : Global Market for Enzyme Inhibitors in Cardiovascular Disease, by Region, Through 2022
Table 50 : Global Market for Enzyme Inhibitors in Gastrointestinal Disorders, by Region, Through 2022
Table 51 : Global Market for Enzyme Inhibitors in HIV/AIDS, by Region, Through 2022
Table 52 : Global Market for Enzyme Inhibitors in Hepatitis, by Region, Through 2022
Table 53 : Global Market for Enzyme Inhibitors in Cancer, by Region, Through 2022
Table 54 : Global Market for Enzyme Inhibitors in Men's Health, by Region, Through 2022
Table 55 : Global Market for Enzyme Inhibitors in Diabetes, by Region, Through 2022
Table 56 : Global Market for Enzyme Inhibitors in Other Sectors, by Region, Through 2022
Table 57 : Leading Manufacturers/Suppliers of Proton Pump Inhibitors, 2016
Table 58 : Market Share of Leading Manufacturers/Suppliers of Proton Pump Inhibitors, 2016
Table 59 : Leading Manufacturers/Suppliers of Protease Inhibitors, 2016
Table 60 : Market Share of Leading Manufacturers/Suppliers of Protease Inhibitors, 2016
Table 61 : Leading Manufacturers/Suppliers of Reverse Transcriptase Inhibitors, 2016
Table 62 : Market Share of Leading Manufacturers/Suppliers of Reverse Transcriptase Inhibitors, 2016
Table 63 : Leading Manufacturers/Suppliers of Kinase Inhibitors, 2016
Table 64 : Market Share of Leading Manufacturers/Suppliers of Kinase Inhibitors, 2016
Table 65 : Leading Manufacturers of Statins, 2016
Table 66 : Market Share of Leading Manufacturers/Suppliers of Statins, 2016
Table 67 : Leading Manufacturers/Suppliers of Aromatase Inhibitors, 2016
Table 68 : Market Share of Leading Manufacturers/Suppliers of Aromatase Inhibitors, 2016
Table 69 : Leading Manufacturers/Suppliers of Phosphodiesterase 5 Inhibitors, 2016
Table 70 : Market Share of Leading Manufacturers/Suppliers of Phosphodiesterase 5 Inhibitors, 2016
Table 71 : Leading Manufacturers/Suppliers of Neuraminidase Inhibitors, 2016
Table 72 : Market Share of Leading Manufacturers/Suppliers of Neuraminidase Inhibitors, 2016
Table 73 : Leading Manufacturers/Suppliers of Angiotensin-Converting Enzyme Inhibitors, 2016
Table 74 : Market Share of Leading Manufacturers/Suppliers of Angiotensin-Converting Enzyme Inhibitors, 2016
Table 75 : Leading Manufacturers/Suppliers of PARP Inhibitors, 2016
Table 76 : Market Share of Leading Manufacturers/Suppliers of PARP Inhibitors, 2016
Table 77 : Leading Manufacturers/Suppliers of Xanthine Oxidase Inhibitors, 2016
Table 78 : Market Share of Leading Manufacturers/Suppliers of Xanthine Oxidase Inhibitors, 2016
Table 79 : Leading Manufacturers/Suppliers of Phosphodiesterase 4 Inhibitors, 2016
Table 80 : Market Share of Leading Manufacturers/Suppliers of Phosphodiesterase 4 Inhibitors, 2016
Table 81 : Leading Manufacturers/Suppliers of Cyclooxygenase Inhibitors, 2016
Table 82 : Market Share of Leading Manufacturers/Suppliers of Cyclooxygenase Inhibitors, 2016
Table 83 : Leading Manufacturers/Suppliers of 5-Alpha Reductase Inhibitors, 2016
Table 84 : Market Share of Leading Manufacturers/Suppliers of 5-Alpha Reductase Inhibitors, 2016
Table 85 : Leading Manufacturers/Suppliers of Dipeptidyl Peptidase-4 Inhibitors, 2016
Table 86 : Market Share of Leading Manufacturers/Suppliers of Dipeptidyl Peptidase-4 Inhibitors, 2016
Table 87 : Leading Manufacturers/Suppliers of SGLT-2 Inhibitors, 2016
Table 88 : Market Share of Leading Manufacturers/Suppliers of SGLT-2 Inhibitors, 2016
Table 89 : Leading Manufacturers/Suppliers of Integrase Inhibitors, 2016
Table 90 : Market Share of Leading Manufacturers/Suppliers of Integrase Inhibitors, 2016
Table 91 : Leading Manufacturers/Suppliers of Monoamine Oxidase Inhibitors, 2016
Table 92 : Market Share of Leading Manufacturers/Suppliers of Monoamine Oxidase Inhibitors, 2016
Table 93 : Leading Manufacturers/Suppliers of PCSK9 Inhibitors, 2016
Table 94 : Market Share of Leading Manufacturers/Suppliers of PCSK9 Inhibitors, 2016
Table 95 : Leading Manufacturers/Suppliers of Acetylcholinesterase Inhibitors, 2016
Table 96 : Market Share of Leading Manufacturers/Suppliers of Acetylcholinesterase Inhibitors, 2016
Table 97 : Number of Patents Granted for Enzyme Inhibitors, by Year, 2015-March 2017
Table 98 : Number of Patents Awarded for Enzyme Inhibitors, by Type, 2015-March 2017
Table 99 : Number of Patents Awarded for Enzyme Inhibitors, by Company, 2015-March 2017
Table 100 : Number of Patents Awarded for Enzymes Inhibitors, by Country, 2015-March 2017
Table 101 : Patents Issued by Country for Enzyme Inhibitors, 2015-March 2017
Table 102 : Number of Patents for Enzyme Inhibitors, by Patent Assignee, 2015-March 2017
Table 103 : New Drug Approvals for Enzyme Inhibitors, 2015-March 2017
Table 104 : Pipeline Products for Enzyme Inhibitors, by Company as of March 2017
Table 105 : Mergers and Acquisitions of Leading Pharmaceutical Companies in Enzyme Inhibitors, 2015-March 2017
Table 106 : Abbreviations Used in Enzyme Inhibitors

List of Chart

Summary Figure : Global Market for Enzyme Inhibitors, by Type, 2015-2022
Figure 1 : Global Market for Enzyme Inhibitors, by Type, 2015-2022
Figure 2 : Global Market Share of Enzyme Inhibitors, by Type, 2016
Figure 3 : Global Market for Enzyme Inhibitors, by Region, 2015-2022
Figure 4 : Global Market Share of Enzyme Inhibitors, by Region, 2016
Figure 5 : Global Market for Proton Pump Inhibitors, 2015-2022
Figure 6 : Global Market Share of Proton Pump Inhibitors, by Region, 2016
Figure 7 : Global Market for Protease Inhibitors, by Region, 2015-2022
Figure 8 : Global Market Share of Protease Inhibitors, by Region, 2016
Figure 9 : Global Market for Reverse Transcriptase Inhibitors, by Region, 2015-2022
Figure 10 : Global Market Share of Reverse Transcriptase Inhibitors, by Region, 2016
Figure 11 : Global Market for Kinase Inhibitors, by Region, 2015-2022
Figure 12 : Global Market Share of Kinase Inhibitors, by Region, 2016
Figure 13 : Global Market for Statins, by Region, 2015-2022
Figure 14 : Market Share of Statins, by Region, 2016
Figure 15 : Global Market for Aromatase Inhibitors, by Region, 2015-2022
Figure 16 : Market Share of Aromatase Inhibitors, by Region, 2016
Figure 17 : Global Market for Phosphodiesterase 5 Inhibitors, by Region, 2015-2022
Figure 18 : Market Share of Phosphodiesterase 5 Inhibitors, by Region, 2016
Figure 19 : Global Market for Neuraminidase Inhibitors, by Region, 2015-2022
Figure 20 : Global Market Share of Neuraminidase Inhibitors, by Region, 2016
Figure 21 : Global Market for ACE Inhibitors, by Region, 2015-2022
Figure 22 : Global Market Share of ACE Inhibitors, by Region, 2016
Figure 23 : Global Market for PARP Inhibitors, by Region, 2015-2022
Figure 24 : Global Market Share of PARP Inhibitors, by Region, 2016
Figure 25 : Global Market for Xanthine Oxidase Inhibitors, by Region, 2015-2022
Figure 26 : Global Market Share of Xanthine Oxidase Inhibitors, by Region, 2016
Figure 27 : Global Market for Phosphodiesterase 4 Inhibitors, by Region, 2015-2022
Figure 28 : Global Market Share of Phosphodiesterase 4 Inhibitors, by Region, 2016
Figure 29 : Global Market for Cyclooxygenase Inhibitors, by Region, 2015-2022
Figure 30 : Global Market Share of Cyclooxygenase Inhibitors, by Region, 2016
Figure 31 : Global Market for 5-Alpha Reductase Inhibitors, by Region, 2015-2022
Figure 32 : Market Share of 5-Alpha Reductase Inhibitors, by Region, 2016
Figure 33 : Global Market for Dipeptidyl Peptidase-4 Inhibitors, by Region, 2015-2022
Figure 34 : Global Market Share of Dipeptidyl Peptidase-4 Inhibitors, by Region, 2016
Figure 35 : Global Market for SGLT-2 Inhibitors, by Region, 2015-2022
Figure 36 : Global Market Share of SGLT-2 Inhibitors, by Region, 2016
Figure 37 : Global Market for Integrase Inhibitors, by Region, 2015-2022
Figure 38 : Global Market Share of Integrase Inhibitors, by Region, 2016
Figure 39 : Global Market for Monoamine Oxidase Inhibitors, by Region, 2015-2022
Figure 40 : Market Share of Monoamine Oxidase Inhibitors, by Region, 2016
Figure 41 : Global Market for PCSK9 Inhibitors, by Region, 2015-2022
Figure 42 : Global Market Share of PCSK9 Inhibitors, by Region, 2016
Figure 43 : Global Market for Acetylcholinesterase Inhibitors, by Region, 2015-2022
Figure 44 : Market Share of Acetylcholinesterase Inhibitors, by Region, 2016
Figure 45 : Global Market for Enzyme Inhibitors, by Disease Sectors 2015-2022
Figure 46 : Global Market Share of Enzyme Inhibitors, by Disease Sectors, 2016
Figure 47 : Global Market for Enzyme Inhibitors in Cardiovascular Disease, by Region, 2015-2022
Figure 48 : Global Market for Enzyme Inhibitors in Gastrointestinal Disorders, by Region, 2015-2022
Figure 49 : Global Market for Enzyme Inhibitors in HIV/AIDS, by Region, 2015-2022
Figure 50 : Global Market for Enzyme Inhibitors in Hepatitis, by Region, 2015-2022
Figure 51 : Global Market for Enzyme Inhibitors in Cancer, by Region, 2015-2022
Figure 52 : Global Market for Enzyme Inhibitors in Men's Health, by Region, 2015-2022
Figure 53 : Global Market for Enzyme Inhibitors in Diabetes, by Region, 2015-2022
Figure 54 : Global Market for Enzyme Inhibitors in Other Sectors, by Region, 2015-2022
Figure 55 : Market Share of Leading Manufacturers/Suppliers of Proton Pump Inhibitors, 2016
Figure 56 : Market Share of Leading Manufacturers/Suppliers of Protease Inhibitors, 2016
Figure 57 : Market Share of Leading Manufacturers/Suppliers of Reverse Transcriptase Inhibitors, 2016
Figure 58 : Market Share of Leading Manufacturers/Suppliers of Kinase Inhibitors, 2016
Figure 59 : Market Share of Leading Manufacturers/Suppliers of Statins, 2016
Figure 60 : Market Share of Leading Manufacturers/Suppliers of Aromatase Inhibitors, 2016
Figure 61 : Market Share of Leading Manufacturers/Suppliers of Phosphodiesterase 5 Inhibitors, 2016
Figure 62 : Market Share of Leading Manufacturers/Suppliers of Neuraminidase Inhibitors, 2016
Figure 63 : Market Share of Leading Manufacturers/Suppliers of Angiotensin-Converting Enzyme Inhibitors, 2016
Figure 64 : Market Share of Leading Manufacturers/Suppliers of Xanthine Oxidase Inhibitors, 2016
Figure 65 : Market Share of Leading Manufacturers/Suppliers of Phosphodiesterase 4 Inhibitors, 2016
Figure 66 : Market Share of Leading Manufacturers/Suppliers of Cyclooxygenase Inhibitors, 2016
Figure 67 : Market Share of Leading Manufacturers/Suppliers of 5-Alpha Reductase Inhibitors, 2016
Figure 68 : Market Share of Leading Manufacturers/Suppliers of Dipeptidyl Peptidase-4 Inhibitors, 2016
Figure 69 : Market Share of Leading Manufacturers/Suppliers of SGLT-2 Inhibitors, 2016
Figure 70 : Market Share of Leading Manufacturers/Suppliers of Integrase Inhibitors, 2016
Figure 71 : Market Share of Leading Manufacturers/Suppliers of Monoamine Oxidase Inhibitors, 2016
Figure 72 : Market Share of Leading Manufacturers/Suppliers of PCSK9 Inhibitors, 2016
Figure 73 : Market Share of Leading Manufacturers/Suppliers of Acetylcholinesterase Inhibitors, 2016
Figure 74 : Number of Patents Granted for Enzyme Inhibitors, by Year, 2015-March 2017
Figure 75 : Patents Issued by Country for Enzyme Inhibitors, 2015-March 2017
Figure 76 : Number of Patents for Enzyme Inhibitors, by Patent Assignee, 2015-March 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *